clinical trials
Clinical trials for drugs, devices and other treatments or interventions
-
Positive results from trials of an immune therapy in dogs with bone cancer have been used to fast-track the development of the drug to treat children with the same cancer. It highlights how leveraging our genetic similarity can advantage both species.
-
The first blood test for Alzheimer's disease detection has been green-lit by the US Food and Drug Administration, providing a simpler, quicker and less invasive method of diagnosis and speedier intervention. It's a milestone moment for medical science.
-
Some people can’t get their bad cholesterol levels down, even if they take cholesterol-lowering meds. A clinical trial using a combination of existing and not-yet-released cholesterol tablets lowered bad cholesterol by almost half.
-
The first clinical trial comparing semaglutide and tirzepatide, two popular, injectable weight-loss drugs, has been published, examining their ability to reduce weight and waist circumference. And one clearly comes out on top.
-
Using an existing steroid-free topical foam daily significantly improved the signs and symptoms of psoriasis on the scalp and the body, according to a recent clinical trial. It could be a game-changer for people with the condition in both places.
-
Clinical trials of a minimally invasive treatment for degenerated spinal discs have produced impressive results, significantly reducing back pain severity and improving function. It may mean delaying surgical intervention or preventing it altogether.
-
The first once-daily oral GLP-1 medication could be on shelves by this time next year, making the weight-loss drug easier to take and potentially cheaper. In the race to be the first, Novo Nordisk has scored a huge win, while Pfizer has failed again.
-
A compound derived from a Himalayan fungus has been refined by scientists for a chemotherapy drug with powerful anti-cancer effects. NUC-7738 is yielding encouraging results in ongoing Phase 2 clinical trials, and is advancing towards approval.
-
A three-year study has found robust evidence that one vaccine for respiratory syncytial virus offers older adults long-term protection, even if efficacy wanes. Despite this, just one dose cut serious illness by nearly two thirds across three seasons.
-
A long-term trial has found that a discontinued drug halved the onset of a genetic form Alzheimer's, from all but 100% to 50%. Buoyed by the results, scientists are now trialing anti-amyloid medication as a preventative for all types of the disease.
-
A mainstay of Parkinson's disease treatment, levodopa can cause nasty side-effects with long-term use. A recent human trial found that a new drug significantly reduces these effects, representing a breakthrough milestone in Parkinson’s treatment.
-
Recent human trials of a new one-year-long immune-based treatment for post-polio syndrome, which can strike polio survivors years after the initial infection and be very debilitating, have produced positive results.
Load More